BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22894890)

  • 1. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study.
    Amsterdam JD; Shults J; Soeller I; Mao JJ; Rockwell K; Newberg AB
    Altern Ther Health Med; 2012; 18(5):44-9. PubMed ID: 22894890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative Antidepressant Effect of Chamomile (
    Amsterdam JD; Li QS; Xie SX; Mao JJ
    J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
    Amsterdam JD; Li Y; Soeller I; Rockwell K; Mao JJ; Shults J
    J Clin Psychopharmacol; 2009 Aug; 29(4):378-82. PubMed ID: 19593179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.
    Keefe JR; Mao JJ; Soeller I; Li QS; Amsterdam JD
    Phytomedicine; 2016 Dec; 23(14):1699-1705. PubMed ID: 27912871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
    Mao JJ; Xie SX; Keefe JR; Soeller I; Li QS; Amsterdam JD
    Phytomedicine; 2016 Dec; 23(14):1735-1742. PubMed ID: 27912875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Matricaria chamomilla (chamomile) extract on pain control of cyclic mastalgia: a double-blind randomised controlled trial.
    Saghafi N; Rhkhshandeh H; Pourmoghadam N; Pourali L; Ghazanfarpour M; Behrooznia A; Vafisani F
    J Obstet Gynaecol; 2018 Jan; 38(1):81-84. PubMed ID: 29072514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial.
    Mao JJ; Li QS; Soeller I; Rockwell K; Xie SX; Amsterdam JD
    J Clin Trials; 2014 Nov; 4(5):. PubMed ID: 29057164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women With Anorexia Nervosa.
    Kimball A; Schorr M; Meenaghan E; Bachmann KN; Eddy KT; Misra M; Lawson EA; Kreiger-Benson E; Herzog DB; Koman S; Keane RJ; Ebrahimi S; Schoenfeld D; Klibanski A; Miller KK
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4347-4355. PubMed ID: 31219558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
    Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF
    J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Byrne G; Bone KM; Adams J; Deed G
    Psychopharmacology (Berl); 2009 Aug; 205(3):399-407. PubMed ID: 19430766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of St John's wort in major depression: a randomized controlled trial.
    Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
    JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M; Klimm HD
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
    Andreatini R; Sartori VA; Seabra ML; Leite JR
    Phytother Res; 2002 Nov; 16(7):650-4. PubMed ID: 12410546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
    Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
    Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial.
    Woelk H; Arnoldt KH; Kieser M; Hoerr R
    J Psychiatr Res; 2007 Sep; 41(6):472-80. PubMed ID: 16808927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.